
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | -- | -- | -- | $0.18 | -- |
08/07/2025 | Q2 | -- | -- | -- | $0.17 | -- |
05/05/2025 | Q1 | $180.2M | $183.5M | $0.17 | $0.17 | -- |
02/19/2025 | Q4 | $178M | $182.3M | $0.19 | $0.17 | $0.02 |
10/31/2024 | Q3 | $175.2M | $178M | $0.13 | $0.16 | -$0.03 |
08/07/2024 | Q2 | $167.6M | $176.1M | $0.10 | $0.15 | -$0.05 |
05/08/2024 | Q1 | $163.8M | $166.7M | $0.11 | $0.14 | -$0.03 |
02/27/2024 | Q4 | $160M | $163.4M | $0.07 | $0.14 | -$0.07 |
11/06/2023 | Q3 | -- | -- | -$0.07 | $0.13 | -$0.20 |
08/07/2023 | Q2 | -- | -- | $0.09 | $0.09 | -- |
05/03/2023 | Q1 | -- | -- | -$0.04 | $0.20 | -$0.24 |
02/21/2023 | Q4 | -- | -- | -$0.37 | $0.32 | -$0.69 |
11/07/2022 | Q3 | -- | -- | -$0.22 | $0.26 | -$0.48 |
08/03/2022 | Q2 | -- | -- | $0.07 | $0.18 | -$0.11 |
05/04/2022 | Q1 | -- | -- | $0.18 | $0.16 | $0.02 |
02/22/2022 | Q4 | -- | -- | -$0.11 | $0.17 | -$0.28 |
11/03/2021 | Q3 | -- | -- | $0.05 | $0.17 | -$0.12 |
08/04/2021 | Q2 | -- | -- | -$0.61 | $0.14 | -$0.75 |
05/05/2021 | Q1 | -- | -- | $0.16 | -- | -- |
02/22/2021 | Q4 | -- | -- | $0.18 | $0.21 | -$0.03 |
11/05/2020 | Q3 | -- | -- | $0.18 | $0.18 | $0.01 |
08/05/2020 | Q2 | -- | -- | $0.14 | $0.12 | $0.02 |
05/06/2020 | Q1 | -- | -- | $0.17 | $0.21 | -$0.04 |
02/24/2020 | Q4 | -- | -- | $0.20 | $0.21 | -$0.00 |
10/30/2019 | Q3 | -- | -- | $0.12 | $0.18 | -$0.06 |
08/07/2019 | Q2 | -- | -- | -- | -- | -- |
05/08/2019 | Q1 | -- | -- | $0.18 | $0.22 | -$0.04 |
02/24/2019 | Q4 | -- | -- | -$0.01 | $0.13 | -$0.14 |
11/05/2018 | Q3 | -- | -- | $0.20 | $0.34 | -$0.15 |
08/08/2018 | Q2 | -- | -- | $0.29 | $0.51 | -$0.22 |
05/09/2018 | Q1 | -- | -- | $0.34 | $0.49 | -$0.15 |
02/21/2018 | Q4 | -- | -- | $0.57 | $0.46 | $0.11 |
11/01/2017 | Q3 | -- | -- | $0.12 | $0.29 | -$0.17 |
08/02/2017 | Q2 | -- | -- | $0.27 | $0.26 | $0.01 |
05/08/2017 | Q1 | -- | -- | $0.27 | $0.32 | -$0.04 |
02/23/2017 | Q4 | -- | -- | $0.62 | $0.57 | $0.05 |
11/03/2016 | Q3 | -- | -- | $0.59 | $0.56 | $0.03 |
08/02/2016 | Q2 | -- | -- | $0.58 | $0.56 | $0.02 |
05/02/2016 | Q1 | -- | -- | $0.56 | $0.56 | -- |
02/22/2016 | Q4 | -- | -- | $0.64 | $0.55 | $0.09 |
11/09/2015 | Q3 | -- | -- | $0.58 | $0.58 | -- |
Sabra Health Care REIT reported $183.5M worth of top line sales in its most recent quarter.
Sabra Health Care REIT announced earnings per share of $0.17 which represents a miss of analyst forecast a $0.17 per share.
Sabra Health Care REIT reported $123.6M that represents $0.51 per share over the last quarter.
Sabra Health Care REIT's earnings are forecast to grow from $0.54 per share to $0.70 per share next year representing an increase of 27.78%.
Sabra Health Care REIT's next earnings date is August 7, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.